This study concluded that PD-L1 intracellular signaling conferred resistance to cancer cells against pro-apoptotic stimuli, including first apoptosis signal receptor (Fas)-Fas ligand (FasL) interactions, among others [91]. The gene discussed is FASLG; the disease is cancer.